Literature DB >> 26137025

Hepatoid adenocarcinoma of the stomach: A case report and review of the literature.

R U Zhou1, Yantao Cai2, Y I Yang2, Jianbin Xiang2, Zongyou Chen2.   

Abstract

Hepatoid adenocarcinoma is a rare tumor, associated with an extremely poor prognosis. In the present report, a 72-year-old female presented to Huashan Hospital (Shanghai, China) with upper abdominal discomfort and, following endoscopy, an ulcerated lesion was observed in the stomach. A computed tomography scan revealed a mass in the antrum of the stomach and the α-fetoprotein level was normal. Sections of the mass exhibited malignant cells arranged in a solid to trabecular pattern; the cells were polygonal shaped with well-defined cytoplasmic borders. Immunohistochemical analysis was performed and the cells were positive for Hep1, CK, CK8, CK18 and P53. The histological features together with the immunohistochemical findings were diagnostic of a hepatoid adenocarcinoma of the stomach. Immunohistochemical studies may aid in the identification of the characteristic features and prevent the misdiagnosis of this tumor.

Entities:  

Keywords:  gastric adenocarcinoma; hepatoid adenocarcinoma; immunohistochemistry

Year:  2015        PMID: 26137025      PMCID: PMC4467275          DOI: 10.3892/ol.2015.2979

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach.

Authors:  Xiaowen Liu; Yufan Cheng; Weiqi Sheng; Hongfen Lu; Xiaoli Xu; Yu Xu; Ziwen Long; Huiyan Zhu; Yanong Wang
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

2.  An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.

Authors:  Xiaowen Liu; Weiqi Sheng; Yanong Wang
Journal:  J Surg Oncol       Date:  2012-03-02       Impact factor: 3.454

3.  Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus.

Authors:  D Gitlin; A Perricelli; G M Gitlin
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

4.  Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation?

Authors:  A Ooi; I Nakanishi; N Sakamoto; Y Tsukada; Y Takahashi; T Minamoto; M Mai
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

5.  Histologic and immunohistochemical analyses of α-fetoprotein--producing cancer of the stomach.

Authors:  Tetsu Kinjo; Hirokazu Taniguchi; Ryoji Kushima; Shigeki Sekine; Ichiro Oda; Makoto Saka; Takuji Gotoda; Fukunori Kinjo; Jiro Fujita; Tadakazu Shimoda
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

Review 6.  Hepatoid adenocarcinoma of the stomach: report of five cases and review of the literature.

Authors:  Tulay Bakir; Yuksel Aliyazicioglu; Ahmet Bektas; Cigdem Siviloglu; Orhan Ozgur
Journal:  Acta Gastroenterol Belg       Date:  2006 Jul-Sep       Impact factor: 1.316

7.  Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach.

Authors:  Kazuhiro Sentani; Naohide Oue; Naoya Sakamoto; Koji Arihiro; Kazuhiko Aoyagi; Hiroki Sasaki; Wataru Yasui
Journal:  Mod Pathol       Date:  2008-01-18       Impact factor: 7.842

Review 8.  Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.

Authors:  Jiann-Sheng Su; Yu-Tso Chen; Ren-Ching Wang; Chun-Ying Wu; Shou-Wu Lee; Teng-Yu Lee
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

9.  An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report.

Authors:  H Ishikura; Y Fukasawa; K Ogasawara; T Natori; Y Tsukada; M Aizawa
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

10.  Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer.

Authors:  Sun Kyung Baek; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang
Journal:  BMC Gastroenterol       Date:  2011-05-19       Impact factor: 3.067

View more
  4 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

2.  The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis.

Authors:  Kai Zhou; Anqiang Wang; Sheng Ao; Jiahui Chen; Ke Ji; Qifei He; Xin Ji; Xiaojiang Wu; Ji Zhang; Zhongwu Li; Zhaode Bu; Jiafu Ji
Journal:  BMC Cancer       Date:  2020-07-17       Impact factor: 4.430

Review 3.  Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuwen Zhou; Yuqing Wang; Jiaming Yuan; Xuelei Ma
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

4.  Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review.

Authors:  Joshua J X Li; Jacqueline H S Lee; Vicky T C Chan; Mei-Yung Yu
Journal:  Case Rep Pathol       Date:  2018-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.